These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

758 related items for PubMed ID: 26827140

  • 1. Synthesis, molecular docking and biological evaluation of N,N-disubstituted 2-aminothiazolines as a new class of butyrylcholinesterase and carboxylesterase inhibitors.
    Makhaeva GF, Boltneva NP, Lushchekina SV, Serebryakova OG, Stupina TS, Terentiev AA, Serkov IV, Proshin AN, Bachurin SO, Richardson RJ.
    Bioorg Med Chem; 2016 Mar 01; 24(5):1050-62. PubMed ID: 26827140
    [Abstract] [Full Text] [Related]

  • 2. 9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment.
    Makhaeva GF, Lushchekina SV, Boltneva NP, Serebryakova OG, Rudakova EV, Ustyugov AA, Bachurin SO, Shchepochkin AV, Chupakhin ON, Charushin VN, Richardson RJ.
    Bioorg Med Chem; 2017 Nov 01; 25(21):5981-5994. PubMed ID: 28986116
    [Abstract] [Full Text] [Related]

  • 3. Design, synthesis, and evaluation of novel cinnamic acid-tryptamine hybrid for inhibition of acetylcholinesterase and butyrylcholinesterase.
    Ghafary S, Ghobadian R, Mahdavi M, Nadri H, Moradi A, Akbarzadeh T, Najafi Z, Sharifzadeh M, Edraki N, Moghadam FH, Amini M.
    Daru; 2020 Dec 01; 28(2):463-477. PubMed ID: 32372339
    [Abstract] [Full Text] [Related]

  • 4. Kinetics and molecular docking of dihydroxanthyletin-type coumarins from Angelica decursiva that inhibit cholinesterase and BACE1.
    Ali MY, Seong SH, Jung HA, Jannat S, Choi JS.
    Arch Pharm Res; 2018 Jul 01; 41(7):753-764. PubMed ID: 30047040
    [Abstract] [Full Text] [Related]

  • 5. Alkyl 2-arylhydrazinylidene-3-oxo-3-polyfluoroalkylpropionates as new effective and selective inhibitors of carboxylesterase.
    Boltneva NP, Makhaeva GF, Kovaleva NV, Lushchekina SV, Burgart YV, Shchegol'kov EV, Saloutin VI, Chupakhin ON.
    Dokl Biochem Biophys; 2015 Jul 01; 465():381-5. PubMed ID: 26728730
    [Abstract] [Full Text] [Related]

  • 6. Synthesis, molecular docking, and biological activity of 2-vinyl chromones: Toward selective butyrylcholinesterase inhibitors for potential Alzheimer's disease therapeutics.
    Makhaeva GF, Boltneva NP, Lushchekina SV, Rudakova EV, Serebryakova OG, Kulikova LN, Beloglazkin AA, Borisov RS, Richardson RJ.
    Bioorg Med Chem; 2018 Sep 01; 26(16):4716-4725. PubMed ID: 30104121
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and biological evaluation of 3-thiazolocoumarinyl Schiff-base derivatives as cholinesterase inhibitors.
    Raza R, Saeed A, Arif M, Mahmood S, Muddassar M, Raza A, Iqbal J.
    Chem Biol Drug Des; 2012 Oct 01; 80(4):605-15. PubMed ID: 22726458
    [Abstract] [Full Text] [Related]

  • 8. Synthesis, Characterization and Cholinesterase Inhibition Studies of New Arylidene Aminothiazolylethanone Derivatives.
    Channar PA, Shah MS, Saeed A, Khan SU, Larik FA, Shabir G, Iqbal J.
    Med Chem; 2017 Oct 01; 13(7):648-653. PubMed ID: 28266279
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and in vitro evaluation of new derivatives of 2-substituted-6-fluorobenzo[d]thiazoles as cholinesterase inhibitors.
    Imramovský A, Pejchal V, Štěpánková Š, Vorčáková K, Jampílek J, Vančo J, Šimůnek P, Královec K, Brůčková L, Mandíková J, Trejtnar F.
    Bioorg Med Chem; 2013 Apr 01; 21(7):1735-48. PubMed ID: 23462716
    [Abstract] [Full Text] [Related]

  • 10. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
    Riaz S, Khan IU, Bajda M, Ashraf M, Qurat-Ul-Ain, Shaukat A, Rehman TU, Mutahir S, Hussain S, Mustafa G, Yar M.
    Bioorg Chem; 2015 Dec 01; 63():64-71. PubMed ID: 26451651
    [Abstract] [Full Text] [Related]

  • 11. Synthesis, structural characterization, docking, lipophilicity and cytotoxicity of 1-[(1R)-1-(6-fluoro-1,3-benzothiazol-2-yl)ethyl]-3-alkyl carbamates, novel acetylcholinesterase and butyrylcholinesterase pseudo-irreversible inhibitors.
    Pejchal V, Štěpánková Š, Pejchalová M, Královec K, Havelek R, Růžičková Z, Ajani H, Lo R, Lepšík M.
    Bioorg Med Chem; 2016 Apr 01; 24(7):1560-72. PubMed ID: 26947959
    [Abstract] [Full Text] [Related]

  • 12. Novel N-benzylpyridinium moiety linked to arylisoxazole derivatives as selective butyrylcholinesterase inhibitors: Synthesis, biological evaluation, and docking study.
    Vafadarnejad F, Karimpour-Razkenari E, Sameem B, Saeedi M, Firuzi O, Edraki N, Mahdavi M, Akbarzadeh T.
    Bioorg Chem; 2019 Nov 01; 92():103192. PubMed ID: 31446239
    [Abstract] [Full Text] [Related]

  • 13. Novel biphenyl bis-sulfonamides as acetyl and butyrylcholinesterase inhibitors: Synthesis, biological evaluation and molecular modeling studies.
    Mutahir S, Jończyk J, Bajda M, Khan IU, Khan MA, Ullah N, Ashraf M, Qurat-ul-Ain, Riaz S, Hussain S, Yar M.
    Bioorg Chem; 2016 Feb 01; 64():13-20. PubMed ID: 26595185
    [Abstract] [Full Text] [Related]

  • 14. In silico, theoretical biointerface analysis and in vitro kinetic analysis of amine compounds interaction with acetylcholinesterase and butyrylcholinesterase.
    Kandasamy S, Loganathan C, Sakayanathan P, Karthikeyan S, Stephen AD, Marimuthu DK, Ravichandran S, Sivalingam V, Thayumanavan P.
    Int J Biol Macromol; 2021 Aug 31; 185():750-760. PubMed ID: 34216669
    [Abstract] [Full Text] [Related]

  • 15. Design, synthesis and biological evaluation of benzofuran appended benzothiazepine derivatives as inhibitors of butyrylcholinesterase and antimicrobial agents.
    Mostofi M, Mohammadi Ziarani G, Lashgari N.
    Bioorg Med Chem; 2018 Jul 23; 26(12):3076-3095. PubMed ID: 29866481
    [Abstract] [Full Text] [Related]

  • 16. Synthesis, molecular docking, and biological activity of polyfluoroalkyl dihydroazolo[5,1-c][1,2,4]triazines as selective carboxylesterase inhibitors.
    Shchegol'kov EV, Makhaeva GF, Boltneva NP, Lushchekina SV, Serebryakova OG, Rudakova EV, Kovaleva NV, Burgart YV, Saloutin VI, Chupakhin ON, Bachurin SO, Richardson RJ.
    Bioorg Med Chem; 2017 Aug 01; 25(15):3997-4007. PubMed ID: 28578994
    [Abstract] [Full Text] [Related]

  • 17. Design and synthesis of some new carboxamide and propanamide derivatives bearing phenylpyridazine as a core ring and the investigation of their inhibitory potential on in-vitro acetylcholinesterase and butyrylcholinesterase.
    Kilic B, Gulcan HO, Aksakal F, Ercetin T, Oruklu N, Umit Bagriacik E, Dogruer DS.
    Bioorg Chem; 2018 Sep 01; 79():235-249. PubMed ID: 29775949
    [Abstract] [Full Text] [Related]

  • 18. In-silico identification of the binding mode of synthesized adamantyl derivatives inside cholinesterase enzymes.
    Al-Aboudi A, Al-Qawasmeh RA, Shahwan A, Mahmood U, Khalid A, Ul-Haq Z.
    Acta Pharmacol Sin; 2015 Jul 01; 36(7):879-86. PubMed ID: 25937631
    [Abstract] [Full Text] [Related]

  • 19. New piperidine-hydrazone derivatives: Synthesis, biological evaluations and molecular docking studies as AChE and BChE inhibitors.
    Karaman N, Sıcak Y, Taşkın-Tok T, Öztürk M, Karaküçük-İyidoğan A, Dikmen M, Koçyiğit-Kaymakçıoğlu B, Oruç-Emre EE.
    Eur J Med Chem; 2016 Nov 29; 124():270-283. PubMed ID: 27592396
    [Abstract] [Full Text] [Related]

  • 20. Novel cinnamic acid-tryptamine hybrids as potent butyrylcholinesterase inhibitors: Synthesis, biological evaluation, and docking study.
    Ghafary S, Najafi Z, Mohammadi-Khanaposhtani M, Nadri H, Edraki N, Ayashi N, Larijani B, Amini M, Mahdavi M.
    Arch Pharm (Weinheim); 2018 Oct 29; 351(10):e1800115. PubMed ID: 30284339
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.